PlainRecalls
FDA Devices Moderate Class II Ongoing

MEDLINE THERAHONEY GEL, 100% LEPTOSPERMUM SCOPARIUM HONEY, a) REF MNK0005, b) REF MNK0015 wound gel

Reported: June 28, 2023 Initiated: May 3, 2023 #Z-1982-2023

Product Description

MEDLINE THERAHONEY GEL, 100% LEPTOSPERMUM SCOPARIUM HONEY, a) REF MNK0005, b) REF MNK0015 wound gel

Reason for Recall

Medline issued a recall on TheraHoney Wound Gel due to the manufacturer notifying Medline of a sterilization dose audit failure on the wound gel and not augmenting the dose after failure per ISO 11137.

Details

Units Affected
851,328 units
Distribution
Worldwide distribution - US Nationwide and the countries of SINGAPORE, DOMINICAN REPUBLIC, UNITED ARAB EMIRATES, DUBAI, CHINA, PANAMA, CANADA, SAUDI ARABIA, BERMUDA, COLOMBIA, MAURITIUS, KUWAIT.
Location
Northfield, IL

Frequently Asked Questions

What product was recalled?
MEDLINE THERAHONEY GEL, 100% LEPTOSPERMUM SCOPARIUM HONEY, a) REF MNK0005, b) REF MNK0015 wound gel. Recalled by MEDLINE INDUSTRIES, LP - Northfield. Units affected: 851,328 units.
Why was this product recalled?
Medline issued a recall on TheraHoney Wound Gel due to the manufacturer notifying Medline of a sterilization dose audit failure on the wound gel and not augmenting the dose after failure per ISO 11137.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 28, 2023. Severity: Moderate. Recall number: Z-1982-2023.